SRL
KYMR icon

Scientech Research LLC’s Kymera Therapeutics KYMR Stock Holding History

Scientech Research LLC’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,379
Closed -$574K – 615
2025
Q4 		$574K Buy
+7,379
New +$498K 0.36% 65
2024
Q2 		– Sell
-11,572
Closed -$465K – 663
2024
Q1 		$465K Buy
+11,572
New +$414K 0.25% 180

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Scientech Research LLC's KYMR Position: Q1 2026 in Review

Scientech Research LLC sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 7,379 shares — an estimated $574K sold.

Scientech Research LLC first reported a position in KYMR in Q1 2024 and held it in 2 quarters. The position peaked at $574K in Q4 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Scientech Research LLC reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 7,379 Kymera Therapeutics shares in Q1 2026, an estimated $574K.
  • Scientech Research LLC first reported a position in Kymera Therapeutics in Q1 2024 and held it in 2 quarters.
  • Scientech Research LLC's Kymera Therapeutics position peaked at $574K in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.